Literature DB >> 31806208

Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure.

Kuniya Asai1, Akihiro Shirakabe2, Kazutaka Kiuchi1, Nobuaki Kobayashi1, Hirotake Okazaki1, Masato Matsushita1, Yusaku Shibata1, Hiroki Goda1, Shota Shigihara1, Kazuhiro Asano1, Kenichi Tani1, Fumitaka Okajima3, Noritake Hata1, Wataru Shimizu4.   

Abstract

Low triiodothyronine (T3) syndrome has recently been evaluated as a prognostic marker of acute heart failure (AHF). However, in which cases low T3 syndrome typically leads to adverse outcomes remain unclear. Of 1,432 AHF patients screened, 1,190 were enrolled. Euthyroidism was present in 956 patients (80.3%), who were divided into 2 groups: the normal group (n = 445, FT3 ≥1.88 µIU/L) and low-FT3 group (n = 511, FT3 <1.88 µIU/L). The survival rates and event-free rates within 365 days were significantly lower in the low-FT3 group than in the normal group. A multivariate Cox regression model showed that the low-FT3 group was an independent predictor of 365-day mortality (hazard ratio [HR] 1.429, 95% confidence interval [CI] 1.013 to 2.015) and HF events (HR 1.349, 95% CI 1.047 to 1.739). The multivariate logistic regression analysis revealed that age (per 10-year old increase, odds ratio [OR]: 1.186, 95% CI: 1.046 to 1.345) and prognostic nutritional index (PNI; per 1-point increase, OR: 1.067, 95% CI: 1.046 to 1.089) were independently associated with the low-FT3 group. The prognosis in patients with a low PNI and over 75 years old, including all-cause death within 365 days, was significantly poorer in the low-FT3 group than in the normal group. In conclusion, adverse outcomes were predicted by the presence of low T3. AHF patients with low T3 syndrome are strongly associated with aging and malnutrition. Low T3 syndrome complicated with older age and malnutrition is likely to lead to adverse outcomes in patients with AHF.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31806208     DOI: 10.1016/j.amjcard.2019.10.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Evaluation of Thyroid Function in Patients Hospitalized for Acute Heart Failure.

Authors:  Ana Rita Leite; João Sérgio Neves; Marta Borges-Canha; Catarina Vale; Madalena von Hafe; Davide Carvalho; Adelino Leite-Moreira
Journal:  Int J Endocrinol       Date:  2021-03-31       Impact factor: 3.257

2.  Non-thyroidal illness syndrome predicts outcome in adult critically ill patients: a systematic review and meta-analysis.

Authors:  Josi Vidart; Paula Jaskulski; Ana Laura Kunzler; Rafael Aguiar Marschner; André Ferreira de Azeredo da Silva; Simone Magagnin Wajner
Journal:  Endocr Connect       Date:  2022-02-09       Impact factor: 3.335

3.  Thyroid function and age-related decline in kidney function in older Chinese adults: a cross-sectional study.

Authors:  Lu Wei; Yun Bai; Yu Zhang; Zhenzhu Yong; Bei Zhu; Qun Zhang; Weihong Zhao
Journal:  BMC Geriatr       Date:  2022-03-17       Impact factor: 3.921

4.  Relationship between Nutritional Status and Clinical and Biochemical Parameters in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction, with 1-year Follow-Up.

Authors:  Marta Kałużna-Oleksy; Helena Krysztofiak; Jacek Migaj; Marta Wleklik; Magdalena Dudek; Izabella Uchmanowicz; Maciej Lesiak; Ewa Straburzyńska-Migaj
Journal:  Nutrients       Date:  2020-08-04       Impact factor: 5.717

5.  Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure.

Authors:  Xinke Zhao; Rongcheng Zhang; Hugang Jiang; Kai Liu; Chengxu Ma; Ming Bai; Tao An; Younan Yao; Xinqiang Wang; Ming Wang; Yingdong Li; Yuhui Zhang; Jian Zhang
Journal:  BMC Endocr Disord       Date:  2021-07-02       Impact factor: 2.763

6.  Analysis of the Incidence of Euthyroid Sick Syndrome in Comprehensive Intensive Care Units and Related Risk Factors.

Authors:  Jianying Guo; Yanyan Hong; Zhiyong Wang; Yukun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.